Top Stories for the Week of August 14th 2006

Tuesday, August 15, 2006 10:13 AM

Top News

SFBC Changes Name to PharmaNet Development Group

Now just emerging from a year of legal and financial blows and bad publicity, SFBC has decided to change its name to PharmaNet Development Group, pending shareholder approval later this month.

Quintiles Creates Strategic Biostatistics Unit

Raleigh, N.C.-based Quintiles has created a statistical working group called the Strategic Biostatistics Unit, which provides guidance to clients on using advanced statistical methods to adjust such variables as the number of patients, trial length, dosing arms and including safety and efficacy endpoints. Applying such methods to protocol design early can offer sponsors significant cost and time savings without statistically invalidating trial data. In addition, the unit’s expertise can develop adaptive clinical trial designs.

Other breaking news...

i3 Research adds another specialty…

eResearch Technology reported second quarter earnings

Company Profile: An interview with Remko van Leeuwen, director, business development, and Kees Groen, executive director of drug development IATEC.

To read the full articles for this issue or for more information on these and other breaking stories, please click here!

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs